Depletion of polyamines and increase of transforming growth factor-β1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts

被引:7
|
作者
Stabellini, G
Moscheni, C
Gagliano, N
Dellavia, C
Calastrini, C
Ferioli, ME
Gioia, M
机构
[1] Univ Milan, Dept Human Morphol, Interdisciplinary Labs Adv Technol, Milan, Italy
[2] Univ Ferrara, Sect Histol & Embryol, Dept Morphol & Embryol, I-44100 Ferrara, Italy
[3] Univ Milan, Inst Biomed Tech, Natl Res Ctr, Milan, Italy
关键词
comparison studies; genes; c-myc; growth factors; transforming; putrescine; spermidine; spermine;
D O I
10.1902/jop.2005.76.3.443
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The polyamines spermidine, spermine, and putrescine are known to be deeply linked with growth processes, gene expression, and extracellular matrix synthesis. Their cellular content depends primarily on the activity of the enzyme ornithine decarboxylase. High levels of ornithine decarboxylase and polyamines have been found in proliferative, inflammatory, and neoplastic pathologies of the oral cavity and in gingival fluid. Difluoromethylornithine (DFMO) selectively inhibits ornithine decarboxylase, thus depleting polyamine content and preventing cell proliferation and synthesis activity. The aim of this study was to investigate whether DFMO treatment could modify the genes involved in cell proliferation and extracellular matrix turnover. Methods: Fibroblasts derived from non-inflamed gingiva were maintained in Dulbecco's modified Eagle's medium (DMEM) plus alpha-difluoromethylornithine for 4 days. At 0, 24, 48, 72, and 96 hours cell number was assessed, polyamine levels were quantified with high performance liquid chromatography (HPLC) method, and transforming growth factor-beta(1) (TGF-beta), c-myc, matrix metalloproteinases (MMP)-1 and 2, Collagen type I (COL-1) and tissue inhibitor of matrix metalloproteinases (TIMP)-1 were evaluated by reverse transcription-polymerase chain reaction (RT-PCR). Results: Fibroblasts treated with DFMO significantly decreased cell proliferation, ornithine decarboxylase activity, and putrescine levels at all treatment times, spermidine after 72 and 96 hours, and spermine after 96 hours of culture. Total polyamines decreased (P <= 0.01) at 96 hours after DFMO treatment, while c-myc, TGF-beta(1), MMP-1 and 2, COL-I mRNA significantly increased. Conversely, TIMP-1 did not show any significant change. The polyamines trend was not correlated to c-myc, TGF-beta(1), MMP-1 and -2, and TIMP-1 mRNA levels. Transforming growth factor-P, and c-myc mRNA expression were related and correlated to MMP-1 and 2, COL-1 and TIMP-1 mRNA trend after DFMO treatment. Conclusions: Our data show that as the polyamine content decreases, TGF-beta(1), c-myc, MMP-1 and -2, and COL-1 mRNA levels increase, therefore a negative regulatory role of the polyamines on the mRNA expression could be suggested.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 50 条
  • [1] The effect of narrowband ultraviolet B on the expression of matrix metalloproteinase-1, transforming growth factor-β1 and type I collagen in human skin fibroblasts
    Choi, C. P.
    Kim, Y. I.
    Lee, J. W.
    Lee, M. H.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 180 - 185
  • [2] Transforming Growth Factor-β1 Bioassay Involving Matrix Metalloproteinase-2 Induction
    Kim, Gi-Hyun
    Kang, So-Young
    Kwak, Ho-Jung
    Baek, Kyung-Min
    Hong, Seung-Hwa
    Lee, Hwa-Jeong
    Sohn, Yeo-Won
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2010, 30 (09): : 667 - 672
  • [3] Effects of nifedipine and interleukin-1α on the expression of collagen, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts
    Sakagami, G.
    Sato, E.
    Sugita, Y.
    Kosaka, T.
    Kubo, K.
    Maeda, H.
    Kameyama, Y.
    JOURNAL OF PERIODONTAL RESEARCH, 2006, 41 (04) : 266 - 272
  • [4] Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts:: the role of protein kinase C
    Domeij, H
    Modéer, T
    Yucel-Lindberg, T
    JOURNAL OF PERIODONTAL RESEARCH, 2004, 39 (05) : 308 - 314
  • [5] Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-β1 in airway fibroblasts in asthma
    Firszt, Rafael
    Francisco, Dave
    Church, Tony D.
    Thomas, Joseph M.
    Ingram, Jennifer L.
    Kraft, Monica
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (02) : 464 - 473
  • [6] Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3
    Yuan, WH
    Varga, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38502 - 38510
  • [7] Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts
    Jinnin, M
    Ihn, H
    Mimura, Y
    Asano, Y
    Yamane, K
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) : 324 - 330
  • [8] Transforming growth factor-β1 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis factor-α
    Ye, Hong
    Cai, Peng-Cheng
    Zhou, Qiong
    Ma, Wan-Li
    WOUND REPAIR AND REGENERATION, 2011, 19 (03) : 392 - 399
  • [9] Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1
    Ohyama, Tatsuya
    Yamazaki, Yuichi
    Sato, Ken
    Horiguchi, Norio
    Ichikawa, Takeshi
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    LIVER INTERNATIONAL, 2011, 31 (04) : 572 - 584
  • [10] In vitro expression of matrix metalloproteinase-1, tissue inhibitor of metal loproteinase-1 and transforming growth factor-β1 in human periodontal ligament fibroblasts
    Nahm, DS
    Kim, HJ
    Mah, J
    Baek, SH
    EUROPEAN JOURNAL OF ORTHODONTICS, 2004, 26 (02) : 129 - 135